Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03726554 · ClinicalTrials.gov registry record · NA

Post-Market Study of Comprehensive Reverse Augmented Glenoid and Mini Humeral Tray in Total Shoulder Arthroplasty

A NA study of Post Traumatic Arthritis and Osteoarthritis of the Shoulder, sponsored by Zimmer Biomet.

Active
Registry status
NA
Development phase
99
Enrollment target
6
Study locations

NCT03726554 is a NA study of Post Traumatic Arthritis and Osteoarthritis of the Shoulder that is active but no longer recruiting, run by Zimmer Biomet. The registered enrollment target is 99 participants, below the 147-participant average among 13 other Post Traumatic Arthritis trials with a reported enrollment target (33% lower). The trial reports 6 study locations across 6 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03726554, a NA study of Post Traumatic Arthritis and Osteoarthritis of the Shoulder, is active but no longer recruiting, sponsored by Zimmer Biomet.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
99 participants
Enrollment target
6
Study locations

Study Summary

This study is a multicenter, prospective, non-randomized, non-controlled, dual cohort post market surveillance study. The primary objective of this study is to confirm the safety and performance of the Comprehensive Reverse Shoulder System when used with the Comprehensive Porous Augmented Glenoid Baseplate and/or Comprehensive Mini Humeral Tray in primary and revision reverse shoulder arthroplasty.

Interventions

  • DEVICE Comprehensive Reverse Porous Augmented Glenoid
  • DEVICE Comprehensive Mini Humeral Tray

Study Locations (6)

Florida

  • Andrews Research and Education Foundation - Gulf Breeze

Kentucky

  • Norton Orthopedic Specialists - Louisville

Michigan

  • William Beaumont Hospital - Royal Oak

New York

  • The Research Foundation for the State University of New York - Buffalo

Tennessee

  • Campbell Foundation - Germantown

Virginia

  • The Rector and Visitors of the University of Virginia - Charlottesville

Trial Details

FieldValue
Enrollment Target 99 participants
Start Date 2018-08-28
Est. Completion 2030-02
Phase NA

Sponsor

Zimmer Biomet

115 total trials

What the Registry Record Tells You About NCT03726554

The ClinicalTrials.gov registry entry for NCT03726554 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 99 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 147-participant average among 13 other Post Traumatic Arthritis trials with a reported enrollment target (33% lower). The listed sponsor is Zimmer Biomet, which has 115 total studies on file at ClinicalTrials.gov.

The record links to 5 conditions, with Post Traumatic Arthritis appearing as the primary indexed condition, and to 2 interventions - of which Comprehensive Reverse Porous Augmented Glenoid is the first listed.

NCT03726554 reports 6 study locations spanning 6 distinct geographic areas - top geographies include Florida, Kentucky, Michigan.

Frequently Asked Questions

What is clinical trial NCT03726554 about?

NCT03726554 is a clinical study titled "Post-Market Study of Comprehensive Reverse Augmented Glenoid and Mini Humeral Tray in Total Shoulder Arthroplasty". This study is a multicenter, prospective, non-randomized, non-controlled, dual cohort post market surveillance study. The primary objective of this study is to confirm the safety and performance of the Comprehensive Reverse Shoulder System when used with the Comprehensive Porous Augmented Glenoid Ba...

What is the current status of trial NCT03726554?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 99 participants. The study started on 2018-08-28. Estimated completion is 2030-02.

What conditions does trial NCT03726554 study?

This clinical trial studies the following conditions: Post Traumatic Arthritis, Osteoarthritis of the Shoulder, Arthropathy of Shoulder Region, Grossly Deficient Rotator Cuff, Rheumatoid Arthritis Without Humeral Metaphyseal Defects.

What interventions are being tested in trial NCT03726554?

The interventions under investigation include: Comprehensive Reverse Porous Augmented Glenoid (DEVICE), Comprehensive Mini Humeral Tray (DEVICE).

Who is sponsoring clinical trial NCT03726554?

This trial is sponsored by Zimmer Biomet, which has 115 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03726554 being conducted?

This trial has 6 study locations across Florida, Kentucky, Michigan, New York, Tennessee. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Post Traumatic Arthritis

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.